Hims & Hers Health, Inc. HIMS
26.00 USD +1.94 (+8.06%)
At closeNov 6, 2026, 7:59 PM EST
26.03 +0.03 +0.12%
After hours · Nov 6, 7:59 PM ET
24.42 Day range 26.24
14.52 52-week range 41.52
- YTD
- -19.93%
- 1 year
- -37.38%
News
benzinga.com Hims & Hers Short Interest Climbs to 23% Ahead of Earnings: Can the Stock Break Out? Hims & Hers Health stock has lost momentum this year. After peaking at $72.78 in 2025, it has slumped about 65% to the current $26.
fool.com Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027? Hims & Hers Health is leveraging a high-growth, subscription-based digital platform to provide personalized treatments for weight loss and sexual health. Intuitive Surgical maintains a dominant…
benzinga.com Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery Eli Lilly partners with Hims & Hers to offer Zepbound and Foundayo directly to telehealth patients with self-pay options starting at $149.
investors.com Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli Lilly Hims & Hers Health inked a deal with Eli Lilly on Friday to sell the company's obesity drugs, further entrenching itself in the GLP-1 space.
barrons.com Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement Hims & Hers stock rises after the company announces an agreement with Eli Lilly to offer the pharma giant's GLP-1s on its consumer platform.
benzinga.com Eli Lilly And Hims & Hers Partner To Expand Access To Zepbound And Orforglipron At Standard Self-Pay Prices Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platformEli Lilly and Company (NYSE:LLY) and Hims & Hers Health, Inc. (NYSE:HIMS) today announced…
seekingalpha.com 3 High Conviction Stocks + Charitable Giving: Tax Alpha With Raul Shah Raul Shah explains how value investing can help investors navigate volatile markets, highlighting opportunities in Hims & Hers (HIMS), ServiceNow (NOW), and UnitedHealth (UNH). HIMS demonstrates…
prnewswire.com HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and…
newsfilecorp.com HIMS DEADLINE TODAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between…
globenewswire.com Hims & Hers Health, Inc. (NYSE:HIMS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Hims & Hers Health, Inc. Securities Lawsuit - Contact Portnoy Law Firm LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Hims & Hers Health, Inc. (NYSE: HIMS) that a securities class action lawsuit has been filed on behalf of…
businesswire.com CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Hims (NYSE: HIMS) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 NEW YORK--(BUSINESS WIRE)---- $HIMS #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims” or the…
businesswire.com HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $HIMS--HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law.
globenewswire.com DEADLINE ALERT for Hims & Hers Health, Inc. (HIMS), Unicycive Therapeutics, Inc. (UNCY), and Papa John's International, Inc. (PZZA): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions Investors in Hims & Hers Health, Inc., Unicycive Therapeutics, Inc., and Papa John's International, Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions…
globenewswire.com HIMS Deadline in 1 Day: Hims & Hers Health, Inc. (NYSE: HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Did you buy HIMS securities between August 4, 2025 and July 29, 2026?
newsfilecorp.com HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Hims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit Hims & Hers seeks dismissal of a consumer lawsuit, arguing upfront disclosures refute claims about user privacy, billing, and cancellations.
benzinga.com 4 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 8 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications FDA warns of risks from unapproved compounded GLP-1 drugs including semaglutide and tirzepatide amid rising adverse event reports.
benzinga.com How Did BONER Meme Coin Create One of Robinhood's Biggest Stories? BONER locks up half of tokenized Hims & Hers supply on Robinhood Chain, briefly sending HIMS tokens to $132 before arbitrage restores prices.
benzinga.com Eli Lilly Announces Results From Real-World Study Of Overweight Or Obese Adults Over 55 Indicating That Staying On Zepbound For Weight Management Lowered Healthcare Costs Over Time For adults over the age of 55, including patients in Medicare's GLP-1 Bridge program, these lower costs translate into meaningful savings as early as 12 months into treatment. This is the first study…- benzinga.com Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $32 Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $27 to $32.
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35 Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight and lowers the price target from $39 to $35.
benzinga.com Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access Hims & Hers CEO Andrew Dudum defends the firm against an FTC lawsuit, discusses dropping GLP-1 drug prices and reveals in-house AI plans.- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33 Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $35 to $33.
benzinga.com Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26 Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.- benzinga.com B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32 B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $30 to $32.
- benzinga.com TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30 TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28 Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and raises the price target from $21 to $28.
benzinga.com Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.
benzinga.com Why Is Hims & Hers Health Stock Falling Tuesday? Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.
benzinga.com OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.- benzinga.com Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42 Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target from $35 to $42.
benzinga.com Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today RKLB, HIMS, ASTS, ACHR, PLUG were among the stocks seen trending on Monday, Aug. 10, 2026.
benzinga.com Hims & Hers Shares Drop After Mixed Q2 Earnings — Details Hims & Hers posted Q2 results - here are the details you need to know.- benzinga.com Hims & Hers Health Sees Q3 Sales $880.000M-$900.000M vs $793.071M Est Hims & Hers Health (NYSE:HIMS) sees Q3 sales of $880.000 million-$900.000 million vs $793.071 million analyst estimate.
benzinga.com Hims & Hers Health Raises FY2026 Sales Guidance from $2.800B-$3.000B to $3.100B-$3.300B vs $2.928B Est Hims & Hers Health (NYSE:HIMS) raises FY2026 sales outlook from $2.800 billion-$3.000 billion to $3.100 billion-$3.300 billion vs $2.928 billion estimate.
benzinga.com Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimate Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over…
benzinga.com Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight? Hims & Hers Health shares are in the spotlight Monday ahead of its second-quarter earnings report due today after the market closes.
benzinga.com Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
benzinga.com Hims & Hers Launches Intelligent AI Care Experience, Debuting With Hers Weight Loss Members To Deliver Personalized Guidance And Real-Time Progress Monitoring Rebuilt from the ground up, the new Hers app puts women in one continuous conversation with their providers, Care Teams, and AI, delivering personalized weight loss support the moment she needs…